Nabriva Therapeutics AG CEO Theodore Schroeder receives $2.5M in 2018
Nabriva Therapeutics AG reports 2018 executive compensation
By ExecPay News
Published: June 14, 2019
Nabriva Therapeutics AG reported fiscal year 2018 executive compensation information on June 14, 2019.
In 2018, four executives at Nabriva Therapeutics AG received on average a compensation package of $1.7M, a 35% increase compared to previous year.
Average pay of disclosed executives at Nabriva Therapeutics AG
Theodore Schroeder, Chief Executive Officer, received $2.5M in total. 69% of Schroeder's compensation, or $1.7M, was in option awards. Schroeder also received $220K in salary, $530K in stock awards, as well as $20K in other compensation.
Colin Broom, Chief Executive Officer, received a compensation package of $2M, which increased by 7% compared to previous year. 37% of the compensation package, or $754K, was in option awards.
Steven Gelone, Chief Operating Officer, earned $1.3M in 2018, a 32% increase compared to previous year.
Francesco Maria Lavino, Chief Commercial Officer, received $1.1M in 2018.
Related executives
You may also like
Source: SEC filing on June 14, 2019.